Peripheral Neuropathies and Disorders
Peripheral Neuropathies and Disorders is a research topic within Neurology. Science Explorer counts 27k research works in it since 1950. 15.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on Guillain-Barré syndrome and related neuropathies, including chronic inflammatory demyelinating polyradiculoneuropathy. It covers the pathogenesis, diagnosis, treatment, and prognosis of these neurological disorders, with a particular emphasis on the role of intravenous immunoglobulin therapy. The cluster also explores the autoimmune nature of these neuropathies and their association with specific antibodies and infections.
- Guillain-Barré Syndrome
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Neurological Disorders
- Autoimmune Neuropathies
- Polyneuropathy
- Intravenous Immunoglobulin
- Pathogenesis
- Diagnosis
- Treatment
- Prognosis
- Research works
- 27k fractional, since 1950
- In the world top 10%
- 4.1k per year above
- Top-10% rate
- 15.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +42% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Peripheral Neuropathies and Disorders research?
By volume, the United States and China publish the most (1.1k and 503 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 503 works
- 3 India 394 works
- 4 Japan 325 works
- 5 Italy 257 works
- 6 United Kingdom 236 works
- 7 Germany 222 works
- 8 France 203 works
- 9 Spain 162 works
- 10 Brazil 148 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Peripheral Neuropathies and Disorders research?
By volume in 2022–2025, Mayo Clinic in Arizona publishes the most Peripheral Neuropathies and Disorders research, followed by Mayo Clinic and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 Mayo Clinic in Arizona United States 20 works
- 2 Mayo Clinic United States 20 works
- 3 All India Institute of Medical Sciences India 20 works
- 4 University College London United Kingdom 20 works
- 5 Cleveland Clinic United States 17 works
- 6 Inserm France 16 works
- 7 Capital Medical University China 16 works
- 8 University of North Carolina at Chapel Hill United States 16 works
- 9 National Institute of Mental Health and Neurosciences India 15 works
- 10 Massachusetts General Hospital United States 14 works
Who are the leading researchers in Peripheral Neuropathies and Disorders?
The most-cited researchers publishing on Peripheral Neuropathies and Disorders include Mohammad Ali Sahraian, Ettore Beghi and М. А. Пирадов.
- 1 Mohammad Ali Sahraian 4.6k citations
- 2 Ettore Beghi 4.6k citations
- 3 М. А. Пирадов 2.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Peripheral Neuropathies and Disorders research done?
The largest centres of Peripheral Neuropathies and Disorders research in 2022–2025 are Beijing (China), Tokyo (Japan), London (United Kingdom) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Rochester and Scottsdale.
Largest cities, 2022–2025
Where it is the local speciality
- RochesterUS · 20.4 works9.5×
- ScottsdaleUS · 21.2 works8.2×
Location quotient: how much more of its research is in Peripheral Neuropathies and Disorders than the world average.
Where is the best place to study Peripheral Neuropathies and Disorders?
Among universities, judged by research, Medical University of Vienna, University College London and University of Verona score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of Vienna Austria | 69.6 | 35.0% | 8.7× | 14 | +29.5% |
| 2 | University College London United Kingdom | 55.7 | 27.3% | 2.7× | 20 | +29.1% |
| 3 | University of Verona Italy | 52.1 | 31.7% | 6.7× | 8 | +97.4% |
| 4 | Universitat Autònoma de Barcelona Spain | 49.2 | 39.7% | 3.5× | 8 | +90.0% |
| 5 | All India Institute of Medical Sciences India | 46.9 | 1.4% | 6.2× | 20 | +155.7% |
| 6 | National and Kapodistrian University of Athens Greece | 46.1 | 27.2% | 4.7× | 12 | +12.7% |
| 7 | University of Oxford United Kingdom | 45.9 | 34.5% | 1.9× | 13 | -9.0% |
| 8 | Harvard University United States | 43.4 | 24.9% | 2.1× | 14 | +29.7% |
| 9 | Post Graduate Institute of Medical Education and Research India | 42.3 | 4.8% | 8.2× | 14 | +79.5% |
| 10 | Karolinska Institutet Sweden | 42.3 | 29.2% | 3.6× | 8 | +9.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Peripheral Neuropathies and Disorders research growing?
Output in 2018–2022 was 42% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Peripheral Neuropathies and Disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.